Continuing Education for Pharmacists
In an effort to address the opioid abuse crisis in Virginia, the Board of Pharmacy has determined that all current active pharmacists must obtain at least 1 hour of continuing education (CE) in 2017 which focuses on proper opioid use, opioid overdose prevention, or naloxone administration. Visit the Board of Pharmacy online to learn more about this new requirement.
“Opioid Use and Pain Management Quality and Safety”, a 1-hour continuing education course for pharmacists sponsored by a partnership between Health Quality Innovators (HQI) and the Virginia Pharmacists Association (VPhA) is now available. Licensed pharmacists can learn more about the program on the VPhA website.
In March 2016, the Centers for Disease Control and Prevention (CDC) published the Guideline for Prescribing Opioids for Chronic Pain in the Morbidity and Mortality Weekly Reportand JAMA. The guideline includes recommendations to improve patient safety and care for people with chronic pain. CDC also developed a variety of user-friendly resources to make the guideline easy for both providers and patients to understand and use.
A new brochure specifically for pharmacists outlines some aspects of the pharmacist’s role, important information that pharmacists can share with their patients, and even tips on how to engage in meaningful discussions with patients.
Resources from the Virginia Board of Pharmacy
- Licensed pharmacists interested in pursuing continued education may wish to consult the Virginia Board of Pharmacy’s Guide to Continuing Pharmacy Education Requirements.
- The Board’s recently updated Protocol for the Prescribing and Dispensing of Naloxone details specific legal requirements for pharmacists when prescribing and dispensing naloxone.